Latest filing published 04 Feb 2022 for Jupiter Emerging & Frontier Income Trust Plc, €12k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
John Scott: trading record in brief
John Scott appears in our data through filings on Jupiter Emerging & Frontier Income Trust PLC shares, published by RNS (LSE). Between 15 May 2017 and 4 February 2022, the trades on record add up to 11 filings.
The open-market record is one-sided, with 11 purchases worth €119k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2022: 1 purchase and no sales on the market.
The median purchase comes to €7,576. 9 out of 11 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 4 February 2022, the filings show an open-market purchase worth €12k in Jupiter Emerging & Frontier Income Trust PLC. The median gap between trade and publication is zero days: most filings appear on the same day. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to John Scott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ £1.0010.0% of flowXLONISIN GB00BDR05757FCA-NSM:4263327Canonical exit: 5 May 2022 (T+90)
- 15,000 shares@ £0.9518100.0% of flowXLONISIN GB00BDR05757FCA-NSM:3816006Canonical exit: 15 Mar 2021 (T+90)
- 15,000 shares@ £1.021216.8% of flowXLONISIN GB00BDR05757FCA-NSM:LSE20191204173932_14335787_20200326185106218_26188Canonical exit: 3 Mar 2020 (T+90)
- 6,017 shares@ £0.97987.7% of flowXLONISIN GB00BDR05757FCA-NSM:LSE20190326140428_14016454_20200326185133022_4491Canonical exit: 24 Jun 2019 (T+90)
- 6,050 shares@ £0.96119.5% of flowXLONISIN GB00BDR05757FCA-NSM:LSE20190123164143_13944612_20200326185115862_9101Canonical exit: 23 Apr 2019 (T+90)
- 7,000 shares@ £0.96989.2% of flowXLONISIN GB00BDR05757FCA-NSM:LSE20180924162455_13802572_20200330111446551_5562Canonical exit: 23 Dec 2018 (T+90)
- 4,817 shares@ £1.064713.0% of flowXLONISIN GB00BDR05757FCA-NSM:LSE20180622164005_13690755_20200330111423495_7117Canonical exit: 20 Sept 2018 (T+90)
- 4,670 shares@ £1.09568.5% of flowXLONISIN GB00BDR05757FCA-NSM:LSE20180323173413_13580072_20200330111426967_6080Canonical exit: 21 Jun 2018 (T+90)
- 4,365 shares@ £1.17497.1% of flowXLONISIN GB00BDR05757FCA-NSM:LSE20180110100416_13491433_20200330111417401_19780Canonical exit: 10 Apr 2018 (T+90)
- 8,900 shares@ £1.097516.2% of flowXLONISIN GB00BDR05757FCA-NSM:LSE20170926153508_13376169_20200330131541077_18700Canonical exit: 25 Dec 2017 (T+90)
- 20,000 shares@ £1.0034.2% of flowXLONISIN GB00BDR05757FCA-NSM:LSE20170515114525_13225607_20200330131531005_11413Canonical exit: 13 Aug 2017 (T+90)
11 of 11 declarations